Trusted by:
Can the degree of meningeal inflammation and cortical pathology be used to stratify early progressive MS patients? Roberta Magliozzi, Ph.D., Imperial College, London, UK
Jennifer S. Graves M.D., Ph.D., University of California at San Francisco will present one of three late-breaking abstracts at ACTRIMS 2016
Opportunities for young investigators to present their findings and consult with established researchers and clinicians were among the primary goals of ACTRIMS Forum 2016. The event drew more than 600 participants to New Orleans.
Abstract describes efficacy of ocrelizumab in patients with PPMS with and without T1 gadolinium-enhancing lesions at baseline in a Phase III, placebo-controlled trial.
The Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) recognized the research contributions of five young investigators during the recent ACTRIMS Forum 2018. Abstracts and posters can be found in the ACTRIMS Forum online program, and will be published in the MS Journal.
Dr. Rhonda Voskuhl professor at the University of California, Los Angeles, will present her hypothesis that molecular mechanisms underlying each disability may differ from each other based on regional differences in neurons, astrocytes and oligodendrocytes as the subject of the keynote Kenneth P. Johnson Memorial Lecture on the opening day of the ACTRIMS Forum 2019.
Approximately 1,200 researchers and clinicians are expected to attend the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) annual Forum Feb. 27-29, 2020, in West Palm Beach, Florida.
Dr. Peter Calabresi, professor of Neurology and Neuroscience at the Johns Hopkins School of Medicine and Director of the Johns Hopkins Multiple Sclerosis (MS) Center, will present his team’s discovery of a possible link between severe damage and C3 and C1q gene variants, and how this information could lead to improvements in the ways MS and other neurodegenerative diseases are treated, during his keynote Kenneth P. Johnson Memorial Lecture on the opening day of the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2020.
Multiple Sclerosis Facts and Figures
Multiple Sclerosis Facts and Figures
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right